Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
Most Read
Managing bleeding in cancer: from anticoagulants to artificial intelligence
Our speakers, Mari Thomas and Miren Taberna, shared some recent updates on the management of bleeding in...
An interview with Dr. Alok Khorana
We met with Dr. Alok Khorana in Berlin during the ISTH 2017 Congress. He could not hide his enthusiasm about the...
Polypharmacy in the Older Adult CAT Population
During the ICTHIC webinar titled “Challenges in the management of fragile CAT patients (older patient population...
Modeling predictors and outcomes in myeloproliferative neoplasms and thrombosis
Myeloproliferative neoplasms (MPNs) are characterized by clonal expansion of abnormal hematopoietic stem cells, which...
Real-world CAT patient profile from the RIETE registry
During the ICTHIC webinar, “What is the profile of the real-world CAT patient?”, Dr. Laurent Bertoletti gave a...
KRAS-activating mutations: an independent risk factor for VTE?
Colorectal cancer (CRC) is the third most common type of cancer in Europe , after breast and prostate cancer, and...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
Abstract submission now open for ESMO 2023
Time to submit your abstract for the next European Society for Medical Oncology (ESMO) Congress. The ESMO...
New Predictive Model for Bleeding in Anticoagulated VTE Cancer Patients – (B-CAT Score)
In patients with active cancer who develop venous thromboembolism (Ca-VTE), major bleeding emerges as the most serious...